John A Hey

3PUBLICATIONS
0CO-AUTHORS
BiomaterialsGene and molecular therapyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 05, 2025
Clinical Pharmacokinetics of Oral ALZ-801/Valiltramiprosate in a 2-Year Phase 2 Trial of APOE4 Carriers with Early Alzheimer's Disease.

John A Hey, Jeremy Y Yu, Susan Abushakra

|Jun 20, 2024
Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer's Disease Using Quantitative Systems Pharmacology Model.

John A Hey, Jeremy Y Yu, Susan Abushakra

|Jun 20, 2024
Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease.

John A Hey, Susan Abushakra, Kaj Blennow

Pageof 1

Frequent Collaborators